Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia

Infection and Immunity

Volumn 65, Issue 10, 1997, Pages 4281-4287

  Hughes, Jayne E ^a,c   Stewart, John ^a   Barclay, G Robin ^b   Govan, John R W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENT COMPONENT C3; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTEGRIN;

ARTICLE; BACTERIAL VIRULENCE; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY BURST; STRAIN DIFFERENCE;

EID: 0030756397     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.10.4281-4287.1997     Document Type: Article

References (46)

1. Aida, Y., K. Kusomoto, K. Nakatomi, H. Takada, M. J. Pabst, and K. Maeda. 1995. An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma. J. Leukocyte Biol. 58:675-682.
2. Berger, M., J. O'Shea, A. S. Cross, T. M. Folks, T. M. Chused, E. J. Brown, and M. J. Frank. 1984. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J. Clin. Invest. 74:1566-1571.
3. Bhat, M. A., M. Tsuda, K. Horiike, M. Nozaki, C. S. Vaidyanathan, and T. Nakazawa. 1994. Identification and characterization of a new plasmid carrying genes for degradation of 2,4-dichlorophenoxyacetate from Pseudomonas cepacia CSV90. Appl. Environ. Microbiol. 60:307-312.
4. Bjerknes, R., and D. Aarskog. 1995. Priming of human polymorphonuclear neutrophilic leukocytes by insulin-like growth factor 1: increased phagocytic capacity, complement receptor expression, degranulation, and oxidative burst. J. Clin. Endocrinol. Metab. 80:1948-1955.
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Brown, R. K., and F. J. Kelly. 1994. Role of free radicals in the pathogenesis of cystic fibrosis. Thorax 49:738-742.
7. Butler, S. L., C. J. Doherty, J. E. Hughes, J. W. Nelson, and J. R. W. Govan. 1995. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J. Clin. Microbiol. 33:1001-1004.
8. Condliffe, A. M., E. R. Chilvers, C. Haslett, and I. Dransfield. 1996. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology 89:105-111.
9. Döring, G. 1994. The role of neutrophil elastase in chronic inflammation. Am. J. Respir. Crit. Care Med. 150:S114-S117.
10. Edwards, S. W. 1995. Cell signalling by integrins and immunoglobulin receptors in primed neutrophils. Trends Biol. Sci. 20:362-367.
11. Elborn, J. S., M. Dodd, J. Maddison, L. E. Nixon, J. Nelson, J. Govan, A. K. Webb, and D. Shale. 1994. Clinical and inflammatory responses in CF patients infected with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr. Pulmonol. Suppl. 10:287.
12. Fridlender, M., J. Inbar, and I. Chet. 1993. Biological control of soilborne plant pathogens by a β-1,3-glucanase-producing Pseudomonas cepacia. Soil Biol. Biochem. 25:1211-1221.
13. Govan, J. R. W., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
14. Govan, J. R. W., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
15. Govan, J. R. W., and S. Glass. 1990. The microbiology and therapy of cystic fibrosis lung infections. Rev. Med. Microbiol. 1:19-28.
16. Govan, J. R. W., J. E. Hughes, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
17. Govan, J. R. W., and J. W. Nelson. 1992. Microbiology of lung infection in cystic fibrosis. Br. Med. Bull. 48:912-930.
18. Hallett, M. B., and D. Lloyds. 1995. Neutrophil priming: the cellular signals that say 'amber' but not 'green.' Immunol. Today 16:264-268.
19. Hancock, I. C., and I. R. Poxton. 1988. Bacterial cell surface techniques. John Wiley and Sons, Chichester, England.
20. Havel, J., and W. Reineke. 1993. Degradation of Aroclor 1221 in soil by a hybrid pseudomonad. FEMS Microbiol. Lett. 108:211-218.
21. Heiman, D. F., M. E. Astiz, E. C. Rackow, D. Rhein, Y. B. Kim, and M. H. Weil. 1990. Monophosphoryl lipid A inhibits neutrophil priming by lipopolysaccharide. J. Lab. Clin. Med. 116:237-241.
22. Homma, Y., Z. Sato, F. Hirayama, K. Konno, H. Shirahama, and T. Suzui. 1989. Production of antibiotics by Pseudomonas cepacia as an agent for biological control of soilborne plant pathogens. Soil Biol. Biochem. 21:723-728.
23. Hughes, J. Personal observation.
24. Johnson, W. M., S. D. Tyler, and K. R. Rozee. 1994. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 32:924-930.
25. Karlsson, A., M. Markfjall, N. Stromberg, and C. Dahlgren. 1995. Escherichia coli-induced activation of neutrophil NADPH-oxidase: lipopolysaccharide and formylated peptides act synergistically to induce release of reactive oxygen metabolites. Infect. Immun. 63:4606-4612.
26. Kharazmi, A., A. Fomsgaard, R. S. Conrad, C. Galanos, and N. Hoiby. 1991. Relationship between chemical composition and biological function of Pseudomonas aeruginosa lipopolysaccharide: effect on human neutrophil chemotaxis and oxidative burst. J. Leukocyte Biol. 49:15-20.
27. Konstan, M. W., K. A. Hilliard, T. M. Norvell, and M. Berger. 1994. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am. J. Respir. Crit. Care. Med. 150:448-454.
28. Krumme, M. L., K. N. Timmis, and D. F. Dwyer. 1993. Degradation of trichloroethylene by Pseudomonas cepacia G4 and the constitutive mutant strain G4 5223 PR1 in aquifer microcosms. Appl. Environ. Microbiol. 59: 2746-2749.
29. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
30. Liao, X., I. Charlebois, C. Quellet, M. J. Morency, K. Dewar, J. Lightfoot, J. Foster, R. Siehnel, H. Schweizer, J. S. Lam, R. E. Hancock, and R. C. Levesque. 1996. Physical mapping of 32 genetic markers on the Pseudomonas aeruginosa PAO1 chromosome. Microbiology 142:79-86.
31. Mahenthiralingam, E., D. A. Simpson, and D. P. Speert. 1997. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J. Clin. Microbiol. 35:808-816.
32. Nelson, D., T. E. S. Delahooke, and I. R. Poxton. 1993. Influence of subinhibitory levels of antibiotics on expression of Escherichia coli lipopolysaccharide and binding of anti-lipopolysaccharide monoclonal antibodies. J. Med. Microbiol. 39:100-106.
33. Nielsen, H., S. Birkholz, L. P. Andersen, and A. P. Moran. 1994. Neutrophil activation by Helicobacter pylori lipopolysaccharides. J. Infect. Dis. 170:135-139.
34. Palfreyman, R. W., M. L. Watson, C. Eden, and A. W. Smith. 1997. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Infect. Immun. 65:617-622.
35. Pitt, T. L., M. E. Kaufmann, P. S. Patel, L. C. A. Benge, S. Gaskin, and D. M. Livermore. 1996. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J. Med. Microbiol. 44: 203-210.
36. Revets, H., P. Vandamme, A. Van Zeebroeck, K. De Boeck, M. J. Struelens, J. Verhaegen, J. P. Ursi, G. Verschraegen, H. Franckx, A. Malfroot, I. Dab, and S. Lauwers. 1996. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Acta Clin. Belg. 51:222-230.
37. Rosales, A. M., L. Thomashow, R. J. Cook, and T. W. Mew. 1995. Isolation and identification of antifungal metabolites produced by rice-associated antagonistic Pseudomonas spp. Phytopathology 85:1028-1032.
38. Shaw, D., I. R. Poxton, and J. R. W. Govan. 1995. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol. Med. Microbiol. 11:99-106.
39. Smith, C. W., S. D. Marlin, R. Rothlein, C. Toman, and D. C. Anderson. 1989. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J. Clin. Invest. 83:2008-2017.
40. + Pseudomonas (Burkholderia) cepacia causing CF center epidemics in North America and Britain. Nat. Med. 1:661-666.
41. Sylvester, F. A., U. S. Sajjan, and J. F. Forstner. 1996. Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. Infect. Immun. 64:1420-1425.
42. Tatnell, P. J., N. J. Russell, J. R. W. Govan, and P. Gacesa. 1996. Colonization of cystic fibrosis patients by non-mucoid Pseudomonas aeruginosa -characterisation of the alginate from mucoid variants. Biochem. Soc. Trans. 24:406S.
43. Tsai, C.-M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharide in polyacrylamide gels. Anal. Biochem. 119:115-119.
44. van Pelt, L. J., R. van Zwieten, R. S. Weening, D. Roos, A. J. Verhoeven, and B. G. J. M. Bolscher. 1996. Limitations on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst. J. Immunol. Methods 191:187-196.
45. Westphal, O., and O. Luderitz. 1954. Chemische Erforschung von Lipopolysacchariden gramnegativer Bakterien. Angew. Chem. 66:407-417.
46. Yee, J., and N. V. Christou. 1993. Neutrophil priming by lipopolysaccharide involves heterogeneity in calcium-mediated signal transduction. J. Immunol. 150:1988-1997.